Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation
暂无分享,去创建一个
D. Lens | S. Grille | N. Trías | A. Brugnini | Mariana Brandes | C. Simões | S. Ranero | María Noel Spangenberg | Víctor E Raggio | Camila Simoes | Joaquín Garcia-Luna | Ana Inés Catalán | Matilde Boada | Lucía Spangenberg
[1] B. Grimbacher,et al. Common Variable Immunodeficiency: More Pathways than Roads to Rome. , 2022, Annual review of pathology.
[2] M. Bonder,et al. Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses , 2022, Nature Communications.
[3] R. Krüger,et al. A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage , 2021, Frontiers in Immunology.
[4] R. Willemze,et al. Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020 , 2021, The British journal of dermatology.
[5] C. Lebbé,et al. Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients , 2020, Cancers.
[6] R. Ameratunga,et al. Defining Common Variable Immunodeficiency Disorders in 2020. , 2020, Immunology and allergy clinics of North America.
[7] Z. Zeng,et al. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract , 2020, Frontiers in Immunology.
[8] C. Cunningham-Rundles,et al. Lymphoproliferative Disease in CVID: a Report of Types and Frequencies from a US Patient Registry , 2020, Journal of Clinical Immunology.
[9] N. Rubin,et al. Mycosis fungoides: developments in incidence, treatment and survival , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[10] C. Cunningham-Rundles,et al. Current Genetic Landscape in Common Variable Immune Deficiency. , 2020, Blood.
[11] A. Maguire,et al. Early-stage Mycosis Fungoides: Epidemiology and Prognosis , 2020, Acta dermato-venereologica.
[12] C. Klemann,et al. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2 , 2019, Front. Immunol..
[13] R. Płoski,et al. A Novel Monoallelic Nonsense Mutation in the NFKB2 Gene Does Not Cause a Clinical Manifestation , 2019, Front. Genet..
[14] E. López-Granados,et al. Epigenetic Deregulation in Human Primary Immunodeficiencies. , 2019, Trends in immunology.
[15] Crina Samarghitean,et al. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans , 2018, The Journal of allergy and clinical immunology.
[16] Anne-Kathrin Kienzler,et al. The role of genomics in common variable immunodeficiency disorders , 2017, Clinical and experimental immunology.
[17] A. Skytthe,et al. Investigating heredity in cutaneous T-cell lymphoma in a unique cohort of Danish twins , 2017, Blood Cancer Journal.
[18] B. Lambrecht,et al. Genes associated with common variable immunodeficiency: one diagnosis to rule them all? , 2016, Journal of Medical Genetics.
[19] J. Byrd,et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia , 2016, Nature Genetics.
[20] Ronald P. Schuyler,et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation , 2015, Nature Genetics.
[21] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[22] J. Drouin,et al. Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies , 2014, BMC Medical Genetics.
[23] Emily M. Coonrod,et al. Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. , 2013, American journal of human genetics.
[24] D. Gillis,et al. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin , 2013, Clinical and experimental immunology.
[25] C. Cunningham-Rundles,et al. Morbidity and mortality in common variable immune deficiency over 4 decades. , 2012, Blood.
[26] C. Cunningham-Rundles,et al. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions , 2009, British journal of haematology.
[27] Shigeaki Nonoyama,et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. , 2007, The Journal of allergy and clinical immunology.
[28] Nicola Pimpinelli,et al. WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.
[29] P. Itin,et al. Familial Cutaneous Mycosis fungoides: Successful Treatment with a Combination of Gemcitabine and Alemtuzumab , 2004, Dermatology.
[30] M. Lapidoth,et al. Mycosis fungoides: HLA class II associations among Ashkenazi and non‐Ashkenazi Jewish patients , 2001, The British journal of dermatology.
[31] K. Sharquie,et al. Mycosis fungoides in identical twins. , 2001, Journal of the American Academy of Dermatology.
[32] E. Harhaj,et al. NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .
[33] L. Notarangelo,et al. Diagnostic Criteria for Primary Immunodeficiencies , 1999 .
[34] R. Kurzrock,et al. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. , 1998, Blood.
[35] I. Vořechovský,et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. , 1995, Clinical immunology and immunopathology.
[36] H. Kerl,et al. Clinicopathologic and Immunologic Features Associated With Transformation of Mycosis Fungoides to Large‐Cell Lymphoma , 1992, The American journal of surgical pathology.
[37] R S Chaganti,et al. Non‐hodgkin lymphoma in common variable immunodeficiency , 1991, American journal of hematology.
[38] L. King,et al. Clinical features associated with transformation of cerebriform T‐cell lymphoma to a large cell process , 1990, Hematological oncology.
[39] J. Greer,et al. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. , 1988, The American journal of pathology.
[40] W. Shelley. Familial mycosis fungoides revisited. , 1980, Archives of dermatology.
[41] M. Sandbank,et al. Mycosis fungoides of prolonged duration in siblings. , 1968, Archives of dermatology.
[42] O. J. Cameron. MYCOSIS FUNGOIDES IN MOTHER AND IN DAUGHTER , 1933 .
[43] C. Cunningham-Rundles,et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. , 2016, The journal of allergy and clinical immunology. In practice.